Call Domestic
Call International
Call Health Check
1066
hemato oncologist
Dr Pavan Kumar Boyella
Oncology : Hemato-oncology
Experience: 14+ Years
Education: MBBS, MD (Internal Medicine), DM (Medical oncology)
icon
English Hindi Telugu Tamil Malayalam Kannada
icon
10:00 - 16:00 Mon - Sat
Book Appointment
Hospital
Select Date
Loading available days...
Available Slots
Book Appointment
icon
icon icon Call Now
×
About Dr Pavan Kumar Boyella

Dr. Pavan Kumar Boyella is a highly skilled and dedicated specialist in the Department of Hematology, Transplant & Cellular Therapy with over 14 years of clinical experience. He holds an MBBS, MD in Internal Medicine, and DM in Medical Oncology, reflecting his extensive training and commitment to excellence in hematologic and oncologic care.

Dr. Boyella has been associated with Apollo Health City, Jubilee Hills, where he provides advanced, evidence-based treatment for patients with complex hematological disorders. His expertise spans acute and chronic leukemias, lymphomas, multiple myeloma, aplastic anemia, and stem cell transplantation, with a special focus on cellular therapies and CAR-T cell treatments.

With a strong research background and multiple publications in reputed national and international journals, Dr. Boyella continues to contribute to the evolving field of hematology and transplant medicine.

Fluent in English, Hindi, Telugu, Tamil, Malayalam and Kannada, he ensures clear and compassionate communication with patients, delivering individualized and comprehensive care aimed at achieving the best possible outcomes.

Read More icon
Ask your query icon
Experience
  • Clinical Assistant Professor  - Dept of Medical oncology and Hematology and Division of Stem cell transplant. Amrita Institute of Medical Sciences ponekera p.o Kochi Sept 2014 to Oct 2015
  • Senior Consultant  and Lead  - Division of Adult Hematolymphoid malignancies and Transplant Basavatarakam IndoAmerican  Cancer Hospital and Research Institute, Road no 10 Banjara Hills, Hyderabad  Since Jan 2016 

Special interest

  • Lymphomas

  • Acute Leukemias, Myelodysplastic Syndromes (MDS), Aplastic Anemia, Multiple Myeloma

  • Stem Cell Transplantation and Cellular Therapies

Awards & Achievements

Over 700 Hematopoietic Stem Cell Transplants (HSCT) performed as Consultant — including Haploidentical, Matched Unrelated Donor (MUD), Matched Sibling Donor (MSD), and Autologous (AUTO) transplants.
awards-icon
Successfully conducted over 15 CAR-T cell therapies.
awards-icon
Performed the first synchronous Autologous Stem Cell Transplant (ASCT) and CAR-T therapy in the country.
awards-icon

Research & Publications

01
Neeraj Sidharthan, Rema Ganapathy, P. Gangadharan, Sumi Soman, Keechilet Pavithran, Raghuveer Prabhu, Haripriya V. Raju, Ayswarya Rajan, Pavankumar Boyella, Rajeswari Arun, M.B.B.S., F.A.A.P., Scott C. Howard, Asha Pillai. Strict Treatment Regimen and Febrile Neutropenia Guidelines Allow Favorable Outcomes for Pediatric ALL in Southern India. Blood, 126(23), December 3, 2015.
02
Sidharthan, N., Fuchs, E., Unni, M., Pavankumar Boyella, et al. (2019). HLA-Mismatched Microtransplantation for Relapsed or Refractory Acute Myeloid Leukemia as a Bridge to Allogeneic Hematopoietic Stem Cell Transplantation. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-019-0761-4
03
Vikram Mathews, Anu Korula, Anupam Chakrapani, Dinesh Bhurani, Jina Bhattacharyya, Manju Sengar, Pankaj Malhotra, Pavan Kumar Boyella, et al. (2023). Management of B-cell Lineage Acute Lymphoblastic Leukemia: Expert Opinion from an Indian Panel via Delphi Consensus Method. Frontiers in Oncology, 13:1171568.
04
Sandhya Devi, G. Faiq Ahmed, Manasi C. Mundada, Rachna Khera, Lavanya Nambaru, Krishnamohan Mallavarapu, Pavan Kumar Boyella, Veerandra Patil, Pallavi Suresh Laddha, Senthil J. Rajappa. Retrospective Study of B Lymphoblastic Leukemia to Assess the Prevalence of TEL/AML1 in South India: A Study of 214 Cases and Review of Literature. Indian Journal of Medical and Paediatric Oncology. DOI: 10.1055/s-0042-1742611
05
Rachna Khera, Faiq Ahmed, Manasi Mundada, Lavanya Nambaru, Sudha S. Murthy, Sandhya Devi G., Senthil J. Rajappa, Krishna Mohan Mallavarapu, A. Santa, Pavan Kumar Boyella. (2018). Acute Myeloid Leukaemia with Gene Mutation: A Correlation with Haematological and Immunophenotypic Characteristics and Our Experience in a Tertiary Care Cancer Center in South India. Turk Patoloji Derg, 34:171–174.
06
Manasi Mundada, Faiq Ahmed, Pavan Kumar Boyella, et al. (2023). Histoplasma Infection in a Case of Multiple Myeloma Presenting as a Diagnostic Conundrum. South Asian Journal of Cancer. DOI: 10.1055/s-0043-1761279
07
Kumar L., Melinkeri S., Ganesan P., Kumar J., Biswas G., Kilara N., Pathalingappa H., Prasad S., Jain M., Mishra S. K., Prasad S., Boyella P. K., Sahoo R. K., Bondarde S., Shah S., Rege M., Deb U., Korde T., Dixit J. (2024). Daratumumab in Indian Patients with Relapsed and Refractory Multiple Myeloma: A Prospective, Multicenter, Phase IV Study. Future Oncology, 20(4):191–205. DOI: 10.2217/fon-2023-0842. PMID: 38116642.
08
Jain H., Karulkar A., Kalra D., Ravikumar S., Shah S., Firfiray A., Pendhari J., Jaiswal A. K., Khan A., Sundharam M., Vaibhaw A., Saroha A., Rajyopadhye S., Basu M., Asija S., Chowdhury A., Beher R., Banik A., Dwivedi A., Purwar S., Narula G., Banavali S., Jain N., Highfill S. L., Stroncek D., Fry T., Melinkeri S., Wilson L., Agarwal N., Aribandi A., Boyella P. K., Shah N. N., Neelapu S. S., Sengar M., Purwar R. (2025). Talicabtagene Autoleucel for Relapsed or Refractory B-cell Malignancies: Results from an Open-label, Multicentre, Phase 1/2 Study. The Lancet Haematology, 12(4): e282–e293. DOI: 10.1016/S2352-3026(24)00377-6. PMID: 40090352.Conference Presentations 
09
B. Pavankumar, K. Pavithran, W. Jose, S. Anita, N. Sidharthan (2013).Low-dose Rasburicase is effective in treatment of adults with tumor lysis syndrome.Presented at Indian Cancer Congress, New Delhi. (Poster Presentation)
10
R. Pillai, S. Anita, B. Pavan Kumar, W. Jose, K. Pavithran, S. Durgapoorna (2013).Hematological toxicity following treatment with Temozolomide for gliomas.Presented at Indian Cancer Congress, New Delhi. (Paper Presentation)
11
M. Jose, P. K. Boyella, N. Krishnan, N. Sidharthan, W. Jose, K. Pavithran (2013).Study of prognostic significance of Neutrophilic/Lymphocytic ratio in patients with Diffuse Large B-cell Lymphoma (DLBCL) treated with R-CHOP or CHOP.Presented at Indian Cancer Congress, New Delhi. (Paper Presentation)
12
Neeraj Sidharthan, Rema Ganapathy, P. Gangadharan, Sumi Soman, Keechilet Pavithran, Raghuveer Prabhu, Haripriya V. Raju, Ayswarya Rajan, Pavankumar Boyella, Rajeswari Arun, M.B.B.S., F.A.A.P., Scott C. Howard, Asha Pillai.Strict Treatment Regimen and Febrile Neutropenia Guidelines Allow Favorable Outcomes for Pediatric ALL in Southern India.Presented at Highlights of ASH Asia Pacific 2016, Brisbane. (Poster Presentation)
13
Ventilator-Associated Pneumonia in ICU (2010)MD (Internal Medicine)
14
Prognostic Significance of Germinal Center B-cell and Non-Germinal Center B-cell Diffuse Large B-cell Lymphomas Categorized Based on Immunohistochemistry Treated with Immunochemotherapy (2014)DM (Medical Oncology)
icon Call Now
Book Appointment icon
image image
Request a Callback

Find Hospital

Find Cardiologist

Find Neurologist

Find Orthopedician

Find Oncologist

Find Gastroenterologist

Find Transplant Surgeon

Find ENT Specialist

Find Pulmonologist

Find Dentist

Find Pediatric

Find Dermatologist

Find Urologist

Find Diabetologist

Find Gynecologist

Find General Physician

Find Psychologist

Find General Surgeon

Request A Call Back
Request Type